This commentary examines harm reduction as a critical yet frequently misunderstood public health approach and argues for its recognition as a fundamental human right grounded in the right to health. It explores how misinformation and punitive drug policies have limited the adoption of evidence-based interventions despite strong global support from international health and human rights bodies. It highlights the effectiveness of harm reduction strategies, including needle and syringe programs, opioid agonist therapy, naloxone distribution, and safer consumption services, in reducing overdose deaths, preventing HIV and hepatitis C transmission, and improving engagement with healthcare systems. By reframing harm reduction as a rights-based obligation rather than a moral debate, this commentary highlights the ethical and legal responsibility of governments to ensure equitable access to lifesaving services. It concludes that integrating harm reduction into national health policies can strengthen public health systems, reduce healthcare costs, and promote dignity and social inclusion for people who use drugs.
Maryam Musa (Wed,) studied this question.